• Je něco špatně v tomto záznamu ?

Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study

J. Beyerle, AN. Holowatyj, M. Haffa, E. Frei, B. Gigic, P. Schrotz-King, J. Boehm, N. Habermann, M. Stiborova, D. Scherer, T. Kölsch, S. Skender, N. Becker, E. Herpel, M. Schneider, A. Ulrich, P. Schirmacher, J. Chang-Claude, H. Brenner, M....

. 2020 ; 29 (2) : 460-469. [pub] 20191118

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012881

Grantová podpora
R01 CA189184 NCI NIH HHS - United States
U01 CA206110 NCI NIH HHS - United States
T32 HG008962 NHGRI NIH HHS - United States
R01 CA207371 NCI NIH HHS - United States
P30 CA042014 NCI NIH HHS - United States

BACKGROUND: Xenobiotic-metabolizing enzymes (XME) play a critical role in the activation and detoxification of several carcinogens. However, the role of XMEs in colorectal carcinogenesis is unclear. METHODS: We investigated the expression of XMEs in human colorectal tissues among patients with stage I-IV colorectal cancer (n = 71) from the ColoCare Study. Transcriptomic profiling using paired colorectal tumor and adjacent normal mucosa tissues of XMEs (GSTM1, GSTA1, UGT1A8, UGT1A10, CYP3A4, CYP2C9, GSTP1, and CYP2W1) by RNA microarray was compared using Wilcoxon rank-sum tests. We assessed associations between clinicopathologic, dietary, and lifestyle factors and XME expression with linear regression models. RESULTS: GSTM1, GSTA1, UGT1A8, UGT1A10, and CYP3A4 were all statistically significantly downregulated in colorectal tumor relative to normal mucosa tissues (all P ≤ 0.03). Women had significantly higher expression of GSTM1 in normal tissues compared with men (β = 0.37, P = 0.02). By tumor site, CYP2C9 expression was lower in normal mucosa among patients with rectal cancer versus colon cancer cases (β = -0.21, P = 0.0005). Smokers demonstrated higher CYP2C9 expression levels in normal mucosa (β = 0.17, P = 0.02) when compared with nonsmokers. Individuals who used NSAIDs had higher GSTP1 tumor expression compared with non-NSAID users (β = 0.17, P = 0.03). Higher consumption of cooked vegetables (>1×/week) was associated with higher CYP3A4 expression in colorectal tumor tissues (β = 0.14, P = 0.007). CONCLUSIONS: XMEs have lower expression in colorectal tumor relative to normal mucosa tissues and may modify colorectal carcinogenesis via associations with clinicopathologic, lifestyle, and dietary factors. IMPACT: Better understanding into the role of drug-metabolizing enzymes in colorectal cancer may reveal biological differences that contribute to cancer development, as well as treatment response, leading to clinical implications in colorectal cancer prevention and management.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012881
003      
CZ-PrNML
005      
20210507101835.0
007      
ta
008      
210420s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/1055-9965.EPI-19-0449 $2 doi
035    __
$a (PubMed)31740522
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Beyerle, Jolantha $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
245    10
$a Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study / $c J. Beyerle, AN. Holowatyj, M. Haffa, E. Frei, B. Gigic, P. Schrotz-King, J. Boehm, N. Habermann, M. Stiborova, D. Scherer, T. Kölsch, S. Skender, N. Becker, E. Herpel, M. Schneider, A. Ulrich, P. Schirmacher, J. Chang-Claude, H. Brenner, M. Hoffmeister, U. Haug, RW. Owen, CM. Ulrich
520    9_
$a BACKGROUND: Xenobiotic-metabolizing enzymes (XME) play a critical role in the activation and detoxification of several carcinogens. However, the role of XMEs in colorectal carcinogenesis is unclear. METHODS: We investigated the expression of XMEs in human colorectal tissues among patients with stage I-IV colorectal cancer (n = 71) from the ColoCare Study. Transcriptomic profiling using paired colorectal tumor and adjacent normal mucosa tissues of XMEs (GSTM1, GSTA1, UGT1A8, UGT1A10, CYP3A4, CYP2C9, GSTP1, and CYP2W1) by RNA microarray was compared using Wilcoxon rank-sum tests. We assessed associations between clinicopathologic, dietary, and lifestyle factors and XME expression with linear regression models. RESULTS: GSTM1, GSTA1, UGT1A8, UGT1A10, and CYP3A4 were all statistically significantly downregulated in colorectal tumor relative to normal mucosa tissues (all P ≤ 0.03). Women had significantly higher expression of GSTM1 in normal tissues compared with men (β = 0.37, P = 0.02). By tumor site, CYP2C9 expression was lower in normal mucosa among patients with rectal cancer versus colon cancer cases (β = -0.21, P = 0.0005). Smokers demonstrated higher CYP2C9 expression levels in normal mucosa (β = 0.17, P = 0.02) when compared with nonsmokers. Individuals who used NSAIDs had higher GSTP1 tumor expression compared with non-NSAID users (β = 0.17, P = 0.03). Higher consumption of cooked vegetables (>1×/week) was associated with higher CYP3A4 expression in colorectal tumor tissues (β = 0.14, P = 0.007). CONCLUSIONS: XMEs have lower expression in colorectal tumor relative to normal mucosa tissues and may modify colorectal carcinogenesis via associations with clinicopathologic, lifestyle, and dietary factors. IMPACT: Better understanding into the role of drug-metabolizing enzymes in colorectal cancer may reveal biological differences that contribute to cancer development, as well as treatment response, leading to clinical implications in colorectal cancer prevention and management.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a aminy $x metabolismus $7 D000588
650    _2
$a antioxidancia $x metabolismus $7 D000975
650    _2
$a karcinogeneze $x patologie $7 D063646
650    _2
$a karcinogeny $x metabolismus $7 D002273
650    _2
$a kolorektální nádory $x patologie $7 D015179
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a stanovení celkové genové exprese $x statistika a číselné údaje $7 D020869
650    _2
$a heterocyklické sloučeniny $x metabolismus $7 D006571
650    _2
$a lidé $7 D006801
650    _2
$a střevní sliznice $x enzymologie $x patologie $7 D007413
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a nekuřáci $x statistika a číselné údaje $7 D000078405
650    _2
$a polycyklické aromatické uhlovodíky $x metabolismus $7 D011084
650    _2
$a prospektivní studie $7 D011446
650    _2
$a kuřáci $x statistika a číselné údaje $7 D000074285
650    _2
$a xenobiotika $x metabolismus $7 D015262
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Holowatyj, Andreana N $u Department of Population Health Sciences, University of Utah, Salt Lake City, Utah $u Huntsman Cancer Institute, Salt Lake City, Utah
700    1_
$a Haffa, Mariam $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
700    1_
$a Frei, Eva $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
700    1_
$a Gigic, Biljana $u Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany
700    1_
$a Schrotz-King, Petra $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
700    1_
$a Boehm, Juergen $u Department of Population Health Sciences, University of Utah, Salt Lake City, Utah $u Huntsman Cancer Institute, Salt Lake City, Utah
700    1_
$a Habermann, Nina $u European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
700    1_
$a Stiborova, Marie $u Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Scherer, Dominique $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany $u Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany
700    1_
$a Kölsch, Torsten $u Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany
700    1_
$a Skender, Stephanie $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
700    1_
$a Becker, Nikolaus $u NCT Cancer Registry, German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Herpel, Esther $u Institute of Pathology, University Hospital, Heidelberg, Germany $u Tissue Bank of the National Center for Tumor Diseases (NCT) Heidelberg, Germany
700    1_
$a Schneider, Martin $u Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany
700    1_
$a Ulrich, Alexis $u Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany
700    1_
$a Schirmacher, Peter $u Institute of Pathology, University Hospital, Heidelberg, Germany
700    1_
$a Chang-Claude, Jenny $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Brenner, Hermann $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany $u German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Hoffmeister, Michael $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
700    1_
$a Haug, Ulrike $u Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany $u Faculty of Human and Health Sciences, University of Bremen, Bremen, Germany
700    1_
$a Owen, Robert W $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
700    1_
$a Ulrich, Cornelia M $u Department of Population Health Sciences, University of Utah, Salt Lake City, Utah. neli.ulrich@hci.utah.edu $u Huntsman Cancer Institute, Salt Lake City, Utah $u Fred Hutchinson Cancer Research Center, Seattle, Washington
773    0_
$w MED00006442 $t Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology $x 1538-7755 $g Roč. 29, č. 2 (2020), s. 460-469
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31740522 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507101834 $b ABA008
999    __
$a ok $b bmc $g 1651121 $s 1133260
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 29 $c 2 $d 460-469 $e 20191118 $i 1538-7755 $m Cancer epidemiology, biomarkers & prevention $n Cancer Epidemiol Biomarkers Prev $x MED00006442
GRA    __
$a R01 CA189184 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA206110 $p NCI NIH HHS $2 United States
GRA    __
$a T32 HG008962 $p NHGRI NIH HHS $2 United States
GRA    __
$a R01 CA207371 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA042014 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace